11-108250683-CTTTTTTT-CTTTTTTTTT

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PVS1_ModerateBP6_Very_Strong

The NM_000051.4(ATM):​c.1236-4_1236-3dupTT variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0067 ( 0 hom. )

Consequence

ATM
NM_000051.4 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.510

Publications

10 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.040562645 fraction of the gene. Cryptic splice site detected, with MaxEntScore 12, offset of 0 (no position change), new splice context is: ctttttttttttttttttAGgct. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
BP6
Variant 11-108250683-C-CTT is Benign according to our data. Variant chr11-108250683-C-CTT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1328273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATMNM_000051.4 linkc.1236-4_1236-3dupTT splice_acceptor_variant, intron_variant Intron 9 of 62 ENST00000675843.1 NP_000042.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATMENST00000675843.1 linkc.1236-18_1236-17insTT intron_variant Intron 9 of 62 NM_000051.4 ENSP00000501606.1

Frequencies

GnomAD3 genomes
AF:
0.000548
AC:
78
AN:
142248
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000285
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000421
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000408
Gnomad SAS
AF:
0.000442
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000626
Gnomad OTH
AF:
0.000514
GnomAD2 exomes
AF:
0.0119
AC:
1939
AN:
163404
AF XY:
0.0122
show subpopulations
Gnomad AFR exome
AF:
0.00886
Gnomad AMR exome
AF:
0.0139
Gnomad ASJ exome
AF:
0.0103
Gnomad EAS exome
AF:
0.0101
Gnomad FIN exome
AF:
0.0118
Gnomad NFE exome
AF:
0.0121
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.00670
AC:
9083
AN:
1356150
Hom.:
0
Cov.:
0
AF XY:
0.00662
AC XY:
4477
AN XY:
675808
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00448
AC:
138
AN:
30780
American (AMR)
AF:
0.00956
AC:
371
AN:
38806
Ashkenazi Jewish (ASJ)
AF:
0.00670
AC:
163
AN:
24326
East Asian (EAS)
AF:
0.00390
AC:
149
AN:
38230
South Asian (SAS)
AF:
0.00827
AC:
650
AN:
78550
European-Finnish (FIN)
AF:
0.00439
AC:
169
AN:
38460
Middle Eastern (MID)
AF:
0.00777
AC:
36
AN:
4632
European-Non Finnish (NFE)
AF:
0.00676
AC:
7070
AN:
1045958
Other (OTH)
AF:
0.00597
AC:
337
AN:
56408
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.283
Heterozygous variant carriers
0
757
1514
2271
3028
3785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000548
AC:
78
AN:
142266
Hom.:
0
Cov.:
0
AF XY:
0.000540
AC XY:
37
AN XY:
68566
show subpopulations
African (AFR)
AF:
0.000285
AC:
11
AN:
38612
American (AMR)
AF:
0.000420
AC:
6
AN:
14270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3394
East Asian (EAS)
AF:
0.000409
AC:
2
AN:
4890
South Asian (SAS)
AF:
0.000444
AC:
2
AN:
4508
European-Finnish (FIN)
AF:
0.00188
AC:
15
AN:
7974
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.000626
AC:
41
AN:
65502
Other (OTH)
AF:
0.000512
AC:
1
AN:
1952
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00836
Hom.:
575

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Aug 26, 2022
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1236-3_1236-2insTT variant in ATM is classified as benign because it has not been reported in individuals with disease, is located in the 3' splice region but computational tools do not predict a splicing impact and affects a multiallelic stretch of Ts. ACMG/AMP criteria applied: BA1 -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

ATM-related cancer predisposition Benign:1
Sep 17, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34325032; hg19: chr11-108121410; API